Dynamic Technology Lab Private Ltd Takes $1.45 Million Position in Bath & Body Works, Inc. $BBWI

Dynamic Technology Lab Private Ltd bought a new stake in Bath & Body Works, Inc. (NYSE:BBWI) in the fourth quarter, Holdings Channel.com reports. The firm bought 72,409 shares of the company’s stock, valued at approximately $1,454,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of BBWI. Global Retirement Partners LLC acquired a new stake in Bath & Body Works during the fourth quarter worth about $31,000. Activest Wealth Management acquired a new stake in Bath & Body Works during the fourth quarter worth about $32,000. Geneos Wealth Management Inc. increased its position in Bath & Body Works by 217.7% during the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after purchasing an additional 801 shares during the last quarter. Parallel Advisors LLC increased its position in Bath & Body Works by 42.6% during the fourth quarter. Parallel Advisors LLC now owns 1,897 shares of the company’s stock worth $38,000 after purchasing an additional 567 shares during the last quarter. Finally, Danske Bank A S acquired a new stake in Bath & Body Works during the third quarter worth about $39,000. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Bath & Body Works Price Performance

Shares of BBWI stock opened at $19.40 on Friday. The firm has a market cap of $3.91 billion, a PE ratio of 5.45, a price-to-earnings-growth ratio of 1.87 and a beta of 1.42. The company has a 50-day moving average of $18.61 and a two-hundred day moving average of $20.07. Bath & Body Works, Inc. has a 1-year low of $14.27 and a 1-year high of $33.96.

Bath & Body Works (NYSE:BBWI) last announced its earnings results on Wednesday, May 27th. The company reported $0.32 earnings per share for the quarter, topping the consensus estimate of $0.29 by $0.03. The company had revenue of $1.38 billion during the quarter, compared to analyst estimates of $1.36 billion. Bath & Body Works had a net margin of 10.03% and a negative return on equity of 45.34%. Bath & Body Works’s revenue was down 3.2% compared to the same quarter last year. During the same quarter last year, the firm posted $0.49 earnings per share. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Sell-side analysts anticipate that Bath & Body Works, Inc. will post 2.62 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, June 19th. Shareholders of record on Friday, June 5th will be paid a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 4.1%. The ex-dividend date of this dividend is Friday, June 5th. Bath & Body Works’s dividend payout ratio (DPR) is 22.47%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the stock. Piper Sandler assumed coverage on shares of Bath & Body Works in a research report on Friday, May 15th. They set a “neutral” rating and a $20.00 price objective for the company. The Goldman Sachs Group cut their price objective on shares of Bath & Body Works from $26.00 to $23.00 and set a “neutral” rating for the company in a research report on Thursday, May 28th. Barclays cut their price objective on shares of Bath & Body Works from $25.00 to $23.00 and set an “equal weight” rating for the company in a research report on Thursday, May 28th. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Bath & Body Works from $21.00 to $22.00 and gave the stock a “hold” rating in a research report on Tuesday, March 3rd. Finally, UBS Group cut their price objective on shares of Bath & Body Works from $22.00 to $19.00 and set a “neutral” rating for the company in a research report on Wednesday, May 20th. Three investment analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Bath & Body Works presently has an average rating of “Hold” and an average target price of $21.93.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.